Anxiolytic-like and antidepressant-like effects of ethanol extract of Terminalia chebula in mice

10.1016/j.jtcme.2021.04.003

Vasudevan Mani；Sultan Sajid；Syed Imam Rabbani；Abdulrahman Saud Alqasir；Hani Abdullah Alharbi；Abdullah Alshumaym

Mood disorders ； Forced swimming test ； Tail suspension test ； Open-field test ； Monoamine oxidase ； Elevated plus maze ； Light-dark box test

Journal of Traditional and Complementary Medicine

11卷6期（2021 / 11 / 01）

493 - 502

英文

Terminalia chebula (T.chebula) fruit is referred as ＂King of Medicines＂ in Tibet and is listed as a key plant in ＂Ayurvedic Materia Medica＂ due to its diverse pharmacological activity. The present study was aimed to investigate the comorbid antidepressant-like and anxiolytic-like effects of ethanol extract from T.chebula fruit using experimental behavioral tests in mice. In addition, the study explored the effects of extract on monoamine oxidase -A (MAO-A) levels in mouse brain. Two doses of the T.chebula extract (100 or 200 mg/kg, p.o.) were treated continuously for fifteen days to mice. Regarding antidepressant-like effects, the treatment of T.chebula extract at both dose (100 or 200 mg/kg, p.o.) levels resulted with significant (p ＜ 0.001) reduction in duration of immobility time and increase in swimming time as compared to control group in forced swimming test. Moreover, both doses declined the duration of immobility time in the tail suspension test and increased the number of crossing in the center area using open-field test. Additionally, the dose 200 mg/kg treatment showed a significant reduction (p ＜ 0.05) in MAO-A activity in mouse brain. For anxiolytic activity, both doses significantly (p ＜ 0.001) improved the time spent in open arm and the number of head dips in elevated plus maze test. The higher duration of time spent in light chamber and higher number of crossing between the light and dark chambers by extract treatment in light-dark box test also supported the anxiolytic behavior. The obtained results supported the antidepressant-like and anxiolytic-like effects of ethanol extract of T.chebula in mice.

1. Alwhaibi, M,Alhawassi, TM(2020).Humanistic and economic burden of depression and anxiety among adults with migraine: a systematic review.Depress Anxiety,37,1146-1159.
2. Arbind, K,Manivannan, E,Chandrasekar, R(2019).Ethnopharmacological review of Terminalia chebula.Bioequiv Bioavailab Int J,3,1-8.
3. Asish, P,Sashi, B.(1993).Triterpenoids and their glycosides from Terminalia chebula.Phytochemistry,32,999-1002.
4. Baluchnejadmojarad, T,Rabiee, N,Zabihnejad, S,Roghani, M(2017).Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: possible involvement of ERb/Nrf 2/HO-1 signaling.Brain Res,1662,23-30.
5. Balunas, MJ,Kinghorn, AD(2005).Drug discovery from medicinal plants.Life Sci.,78,431-441.
6. Can, A,Dao, DT,Terrillion, CE,Piantadosi, SC,Bhat, S,Gould, TD(2012).The tail suspension test.JoVE,59,3769.
7. Chandrasekhar, Y,Kumar, GP,Navya, K,Ramya, EM,Anilakumar, KR(2018).Tannins from Terminalia chebula fruits attenuates GABA antagonist-induced anxietylike behaviour via modulation of neurotransmitters.J Pharm Pharmacol,70,1662-1674.
8. Chandrashekar, R,Manohar, VR,Rao, SN(2012).Antidepressant activity of aqueous extract of fruits of Terminalia chebula in rats.Int J Pharm Pharmaceut Sci.,4,449-451.
9. Chandrashekar, R,Manohar, VR,Rao, SN(2013).Acute anxiolytic activity of aqueous extract of Terminalia chebula fruit pulp in rats.Int J Res Ayurveda Pharm,4,112-115.
10. Chang, CL,Lin, CS(2012).Phytochemical composition, antioxidant activity, and neuroprotective effect of Terminalia chebula Retzius extracts.Evid Based Complementary Altern Med,2012,125247.
11. Chattopadhyay, RR,Bhattacharyya, SK(2007).Plant review - Terminalia chebula: an update.Pharm Rev,1,151-156.
12. Choi, MK,Kim, HG,Han, JM(2015).Hepatoprotective effect of Terminalia chebula against t-BHP-induced acute liver injury in C57/BL6 mice.Evid Based Complement Alternat Med,2015,517350.
13. Coryell, W,Fiedorowicz, JG,Solomon, D(2012).Effects of anxiety on the long-term course of depressive disorders.Br J Psychiatry,200,210-215.
14. Cuijpers, P,Clignet, F,van Meijel, B(2011).Psychological treatment of depression in inpatients: a systematic review and meta-analysis.Clin Psychol Rev.,31,353-360.
15. Curran, E,Rosato, M,Cooper, J,Mc Garrigle, CA,Leavey, G(2019).Symptom profiles of late-life anxiety and depression: the influence of migration, religion and loneliness.Depress Anxiety,36,824-833.
16. Dattatray, BP,Padmaja, AM,Nirmala, NR(2014).Antidepressant activity of aqueous extracts of fruits of Terminalia chebula and Phyllanthus emblica in behavioural models of depression: involvement of monoaminergic system.Int J Pharm Pharmaceut Sci.,6,615.
17. Ecobichon, DJ(1997).The Basis of Toxicology Testing.New York:CRC Press.
18. Ennaceur, A(2014).Tests of unconditioned anxiety d pitfalls and disappointments.Physiol Behav,135,55-71.
19. Fekadu, N,Shibeshi, W,Engidawork, E(2016).Evaluation of the antidepressant-like activity of the crude extract and solvent fractions of Rosa abyssinica Lindley (Rosaceae) using rodent models of depression.Clin Exp Pharmacol,6,1-7.
20. Gupta, P.(2012).Biological and pharmacological properties of Terminalia chebula Retz. (haritaki)- an overview.Int J Pharm Pharmaceut Sci,2,2-10.
21. Jameson, JP,Blank, MB(2010).Diagnosis and treatment of depression and anxiety in rural and nonrural primary care: national survey results.Psychiatr Serv,61,624-627.
22. Jayaramkumar, K(2006).Effect of geographical variation on content of tannic acid, gallic acid, chebulinic acid, and ethyl gallate in Terminalia chebula fruits.Nat Prod,2,170-175.
23. Juang, LJ,Sheu, SJ,Lin, TC(2004).Determination of hydrolyzable tannins in the fruit of Terminalia chebula by high-performance liquid chromatography and capillary electrophoresis.J Separ Sci,27,718-724.
24. Katz, RJ,Roth, KA,Carroll, BJ(1981).Acute and chronic stress effects on open field activity in the rat: implications for a model of depression.Neurosci Biobehav Rev,5,247-251.
25. Kim, YR,Park, BK,Kim, YH,Shim, I,Kang, IC,Lee, MY(2018).Antidepressant effect of Fraxinus rhynchophylla Hance extract in a mouse model of chronic stressinduced depression.BioMed Res Int,2018,8249563.
26. Kraeuter, AK,Guest, PC,Sarnyai, Z(2019).The elevated plus maze test for measuring anxiety-like behavior in rodents.Methods Mol Biol,1916,69-74.
27. Mohan, L,Rao, USC,Gopalakrishna, HN,Nair, V(2011).Evaluation of the anxiolytic activity of NR-ANX-C (a Polyherbal Formulation) in ethanol withdrawal-induced anxiety behavior in rats.Evid Based Complementary Altern Med,2011,327160.
28. Molehin, OR,Adefegha, SA(2014).Comparative study of the aqueous and ethanolic extract of Momordica foetida on the phenolic content and antioxidant properties.Int Food Res J.,21,401-405.
29. Nageswara rao, S,Palaksha, MN,Satish, S,Ravishankar(2013).The effects of ethanolic extract in dried fruits of Terminalia chebula on learning and memory in mice.Asian J Biomed Pharm,3,59-62.
30. Onasanwo, SA,Faborode, SO,Agrawal, M,Ijiwola, OL,Jaiyesimi, BO,Narender, T(2014).Antidepressant and anxiolytic potentials of chebulinic acid in laboratory rodent.Ann Depress Anxiety,1,1032.
31. Peng, GJ,Tian, JS,Gao, XX,Zhou, YZ,Qin, XM(2015).Research on the pathological mechanism and drug treatment mechanism of depression.Curr Neuropharmacol,13,514-523.
32. Peterson, CT,Denniston, K,Chopra, D(2017).Therapeutic uses of triphala in Ayurvedic medicine.J Alternative Compl Med,23,607-614.
33. Porsolt, RD,Le Pichon, M,Jalfre, M(1977).Depression: a new animal model sensitive to antidepressant treatments.Nature,266,730-732.
34. Quidé, Y,Witteveen, AB,El-Hage, W(2012).Differences between effects of psycho- logical versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic review.Neurosci Biobehav Rev,36,626-644.
35. Rajput, MA,Khan, RA(2017).Phytochemical screening, acute toxicity, anxiolytic and antidepressant activities of the Nelumbo nucifera fruit.Metab Brain Dis.,32,743-749.
36. Ramesh, M,Dokurugu, YM,Thompson, MD,Soliman, ME(2017).Therapeutic, molecular and computational aspects of novel monoamine oxidase (MAO) inhibitors.Comb Chem High Throughput Screen,20,492-509.
37. Rizzo, M,Creed, F,Goldberg, D(2011).A systematic review of non-pharmacological treatments for depression in people with chronic physical health problems.J Psychosom Res,71,18-27.
38. Shulman, KI,Herrmann, N,Walker, SE(2013).Current place of monoamine oxidase inhibitors in the treatment of depression.CNS Drugs,27,789-797.
39. Spini, VBMG,Ferreira, FR,Gomes, AO(2020).Maternal immune activation with H1N1 or Toxoplasma gondii antigens induces behavioral impairments associated with mood disorders in rodents.Neuropsychobiology,1-8.
40. Steru, L,Chermat, R,Thierry, B,Simon, P(1985).The tail suspension test: a new method for screening antidepressants in mice.Psychopharmacology,85,367-370.
41. Thomas, SJ,Shin, M,McInnis, MG,Bostwick, JR(2015).Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.Pharmacotherapy,35,433-449.
42. Tzvetkov, NT,Stammler, HG,Neumann, B,Hristova, S,Antonov, L,Gastreich, M(2017).Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.Eur J Med Chem,127,470-492.
43. Ulrich-Merzenich, G,Kelber, O,Koptina, A(2012).Novel neurological and immunological targets for salicylate-based phytopharmaceuticals and for the anti-depressant imipramine.Phytomedicine,19,930-939.
44. Vonshak, A,Barazani, O,Sathiyomoorthy, P,Shalev, R,Vardy, D,Golan-Goldhirsh, A(2003).Screening of South-Indian medicinal plants for anti-fungal activity.Phyther Res,17,1123-1125.
45. Wyska, E(2019).Pharmacokinetic considerations for current state-of-the-art antidepressants.Expet Opin Drug Metabol Toxicol,15,831-847.
46. Yeung, AWK,Georgieva, MG,Atanasov, AG,Tzvetkov, NT(2019).Monoamine oxidases (MAOs) as privileged molecular targets in neuroscience: research literature analysis.Front Mol Neurosci,12,143.
47. Yoshimura, H,Yamakawa, K(2000).Animal models for behavioral disorder in females.Brain Sci,22,49-54.
48. Yu, ZF,Kong, LD,Chen, Y(2002).Antidepressant activity of aqueous extracts of Curcuma longa in mice.J Ethnopharmacol,83,161-165.

1. Shehanshah Wali Moazzam,Mansoor Ahmad Siddiqui,Abdul Mobeen(2022).Efficacy of Jawarish Shahi a herbal formulation in irritable bowel syndrome: An open-labeled single-arm clinical trial.Journal of Traditional and Complementary Medicine,12(6),529-535.